Brevan Howard Capital Management’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.11M Buy
106,216
+95,770
+917% +$5.04M 0.03% 420
2026
Q1
$641K Sell
10,446
-50,060
-83% -$3.58M 0.01% 1157
2025
Q4
$5.02M Buy
60,506
+10,171
+20% +$761K 0.05% 240
2025
Q3
$3.38M Buy
50,335
+5,377
+12% +$389K 0.02% 360
2025
Q2
$3.51M Buy
44,958
+36,374
+424% +$2.79M 0.02% 507
2025
Q1
$657K Buy
+8,584
New +$699K 0.01% 643
2024
Q4
– Sell
-7,928
Closed -$612K – 1111
2024
Q3
$612K Sell
7,928
-3,058
-28% -$228K ﹤0.01% 625
2024
Q2
$747K Buy
+10,986
New +$745K 0.01% 472
2024
Q1
– Sell
-18,635
Closed -$1.41M – 1064
2023
Q4
$1.41M Buy
18,635
+10,718
+135% +$740K 0.02% 169
2023
Q3
$536K Buy
+7,917
New +$546K 0.01% 158

Other funds holding CTSH

Brevan Howard Capital Management's CTSH Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Cognizant (CTSH) stake by 917% in Q2 2026, buying an estimated $5.04M and bringing the position to 106,216 shares worth $4.11M. The position accounts for 0.03% of the portfolio, ranked #420.

Brevan Howard Capital Management first reported a position in CTSH in Q3 2023 and has held it in 10 quarters since. The position peaked at $5.02M in Q4 2025. 918 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.

  • Brevan Howard Capital Management held 106,216 shares of Cognizant worth $4.11M as of Q2 2026.
  • Brevan Howard Capital Management bought 95,770 Cognizant shares in Q2 2026, an estimated $5.04M.
  • Cognizant made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #420 holding.
  • Brevan Howard Capital Management first reported a position in Cognizant in Q3 2023 and has held it in 10 quarters since.
  • Brevan Howard Capital Management's Cognizant position peaked at $5.02M in Q4 2025.
  • 918 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.